Libido Enhancement at Better Med Spa centers on PT‑141 (bremelanotide), a melanocortin receptor agonist that acts in the hypothalamus to enhance sexual desire and arousal rather than just blood flow. Given as a low‑dose subcutaneous injection ahead of anticipated intimacy, this non‑FDA–approved protocol is offered under informed consent and tailored around each client’s health, triggers, and relationship goals.

PT‑141 is a synthetic analog of alpha‑MSH that activates melanocortin receptors (especially MC3R and MC4R) in the hypothalamus, modulating neural circuits involved in sexual desire, arousal, and reward. Unlike PDE‑5 inhibitors, which act primarily via peripheral vasodilation, PT‑141 works centrally, enhancing libido independent of direct vascular effects and often improving both spontaneous desire and responsiveness to erotic cues. In clinical trials, on‑demand PT‑141 has improved distressing low desire (HSDD) in premenopausal women and increased erectile responses in men, with onset typically within about 45 minutes and effects lasting several hours.
Our PT-141 peptide is designed to target:
PT-141 is believed to help with:
Experience the best in aesthetic and wellness care at Better Med Spa. Our personalized treatments are tailored to you, designed to help you look and feel your absolute best with confidence and ease.
We're here to answer your questions and provide the best services for your needs.
PT‑141 (bremelanotide) is a melanocortin agonist that works in the brain to boost desire and arousal, whereas medications like sildenafil work mainly on blood flow to the genitals. Libido Enhancement focuses on the mental/emotional dimension of intimacy—helping clients feel interested, engaged, and responsive again—often layered with or without PDE‑5s depending on their needs.
Bremelanotide is FDA‑approved as Vyleesi for premenopausal women with HSDD, with a labeled on‑demand subcutaneous dosing schedule and clear blood pressure and nausea warnings. Better Med Spa offers PT‑141 in a broader, off‑label Libido Enhancement context under a non‑FDA–approved informed consent model, explaining approved uses, off‑label aspects, and alternatives in detail.
Common side effects include nausea (especially first dose), flushing, injection‑site reactions, and headache; transient increases in blood pressure and decreases in heart rate have also been observed. PT‑141 is generally not appropriate for clients with uncontrolled hypertension, significant cardiovascular disease, pregnancy, or for frequent use beyond labeled limits, so Better Med Spa screens carefully and uses conservative dosing and frequency.
Most clients inject about 45 minutes before anticipated intimacy, with effect lasting several hours, and are typically advised not to use more than one dose in 24 hours or more than a limited number of doses per month to reduce side-effect and blood‑pressure risk. Your exact plan is personalized based on health history, responsiveness, and how PT‑141 fits alongside hormones, PDE‑5s, or psychotherapy.
Libido Enhancement is often paired with hormone evaluation, stress and sleep work, GLP‑1 or metabolic support (when weight or body image affect desire), and relationship‑centered coaching resources. From an operational standpoint, it is a high‑value add‑on for GLP‑1, peptide, and membership clients, with automated follow‑ups to track satisfaction, dosing, and any side effects while nurturing long‑term trust and intimacy‑focused outcomes.